These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma. Lichtenfeld JL; Wiernik PH; Mardiney MR; Zarco RM Cancer Res; 1976 Oct; 36(10):3678-80. PubMed ID: 953991 [TBL] [Abstract][Full Text] [Related]
23. Circulating immune complexes and complement levels in hemophilic children. Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882 [TBL] [Abstract][Full Text] [Related]
24. Complement and circulating immune complexes in children with mumps meningitis. Madaliński K; Imbs D; Gregorek H; Jankowski M; Ułanowicz G; Gut W; Kańtoch M Arch Immunol Ther Exp (Warsz); 1984; 32(5):529-35. PubMed ID: 6534320 [TBL] [Abstract][Full Text] [Related]
25. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor. Long JC; Hall CL; Brown CA; Stamatos C; Weitzman SA; Carey K N Engl J Med; 1977 Aug; 297(6):295-9. PubMed ID: 559938 [TBL] [Abstract][Full Text] [Related]
26. Serial studies of circulating immune complexes in poststreptococcal glomerulonephritis. Lin CY Pediatrics; 1982 Nov; 70(5):725-7. PubMed ID: 7133824 [TBL] [Abstract][Full Text] [Related]
27. [Influence of age on treatment results in children and adolescents with Hodgkin's disease]. Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044 [TBL] [Abstract][Full Text] [Related]
28. Impaired humoral immunity in treated Hodgkin's disease. Weitzman SA; Aisenberg AC; Siber GR; Smith DH N Engl J Med; 1977 Aug; 297(5):245-8. PubMed ID: 301608 [TBL] [Abstract][Full Text] [Related]
29. Circulating immune complexes in Hodgkin's disease. Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278 [TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in sera of dogs with benign and malignant breast disease. Gordon BR; Moroff S; Hurvitz AI; Matus RE; MacEwen EG; Good RA; Day NK Cancer Res; 1980 Oct; 40(10):3627-31. PubMed ID: 7438046 [TBL] [Abstract][Full Text] [Related]
31. Change of complement system predicts the outcome of patients with severe thermal injury. Kang HJ; Kim JH; Lee EH; Lee YK; Hur M; Lee KM J Burn Care Rehabil; 2003; 24(3):148-53. PubMed ID: 12792234 [TBL] [Abstract][Full Text] [Related]
32. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. Bengtsson A; Nezlin R; Shoenfeld Y; Sturfelt G J Autoimmun; 1999 Aug; 13(1):111-9. PubMed ID: 10441175 [TBL] [Abstract][Full Text] [Related]
33. Relationship between immune complex and total hemolytic complement in endolymphatic hydrops. Gutierrez F; Moreno PM; Sainz M Laryngoscope; 1994 Dec; 104(12):1495-8. PubMed ID: 7990640 [TBL] [Abstract][Full Text] [Related]
34. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953 [TBL] [Abstract][Full Text] [Related]
35. [Circulating immune complexes in breast cancer]. Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691 [TBL] [Abstract][Full Text] [Related]
36. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452 [TBL] [Abstract][Full Text] [Related]
37. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495 [TBL] [Abstract][Full Text] [Related]
38. [Conformational changes in C3 levels of complement during storage of blood from Hodgkin's disease patients and from healthy people]. Kniazeva OA; Sakaeva DD; Tiagotin IuV Vopr Onkol; 2000; 46(1):58-60. PubMed ID: 10789225 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations. Riccio A; Reynaud L; Postiglione L; Catalano M; Natale D; Pronestì G; Melfa V; Cicciarello S; Borgia G Boll Soc Ital Biol Sper; 1994; 70(8-9):235-42. PubMed ID: 7893482 [TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle. Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]